# Botensilimab + Balstilimab vs Best Supportive Care as Therapy in Chemo-refractory, Unresectable, Colorectal Adenocarcinoma

> clinical trial · VERIFIED · 2026-06-29

Status: RECRUITING · Sponsor: Canadian Cancer Trials Group · Condition: Colorectal Cancer

- Company: Canadian Cancer Trials Group
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT07152821

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.